159938 医药
已收盘 06-08 15:00:00
资讯
新帖
简况
6月8日海创药业跌7.50%,鹏华医药科技股票A基金重仓该股
证券之星 · 16:43
6月8日海创药业跌7.50%,鹏华医药科技股票A基金重仓该股
医药外包概念股全线走低 金斯瑞生物科技(01548)跌7.43%、药明生物(02269)跌7.39%
金吾财讯 · 13:43
医药外包概念股全线走低 金斯瑞生物科技(01548)跌7.43%、药明生物(02269)跌7.39%
上药益药医药(上海)有限公司成立
证券日报 · 13:36
上药益药医药(上海)有限公司成立
大型医药股表现活跃,指数逆势收涨,医药ETF易方达(512010)本周“吸金”超8亿元
证券之星 · 06-05 19:13
大型医药股表现活跃,指数逆势收涨,医药ETF易方达(512010)本周“吸金”超8亿元
6月5日悦康药业跌15.77%,富国医药创新股票A基金重仓该股
证券之星 · 06-05
6月5日悦康药业跌15.77%,富国医药创新股票A基金重仓该股
创胜集团医药-B(06628)建议委任徐汉森为非执行董事
智通财经 · 06-04
创胜集团医药-B(06628)建议委任徐汉森为非执行董事
差异化创新破局,科望医药领航免疫治疗新蓝海
格隆汇 · 06-04
差异化创新破局,科望医药领航免疫治疗新蓝海
楚天科技:将楚天打造成世界医药领军企业之一
证券之星 · 06-04
楚天科技:将楚天打造成世界医药领军企业之一
长春高新:公司管理团队涵盖医药、企管、财务、法务、金融等多元专业背景
证券之星 · 06-04
长春高新:公司管理团队涵盖医药、企管、财务、法务、金融等多元专业背景
国产双靶点GLP-1迎新进展,翰森制药减重新药申报获受理|医药早参
每日经济新闻 · 06-04
国产双靶点GLP-1迎新进展,翰森制药减重新药申报获受理|医药早参
和誉-B(02256):和誉医药于PAGE会议展示ABSK-011(依帕戈替尼)在HCC患者中的联合建模新框架
智通财经 · 06-04
和誉-B(02256):和誉医药于PAGE会议展示ABSK-011(依帕戈替尼)在HCC患者中的联合建模新框架
宏辉果蔬推进业务结构升级,7亿元控股施美药业拓展医药赛道
长三角资本局 · 06-03
宏辉果蔬推进业务结构升级,7亿元控股施美药业拓展医药赛道
星昊医药(920017)披露2025年年度权益分派实施公告,6月3日股价下跌0.06%
证券之星 · 06-03
星昊医药(920017)披露2025年年度权益分派实施公告,6月3日股价下跌0.06%
欧康医药(920230)披露回购股份注销完成暨股份变动公告,6月3日股价下跌0.93%
证券之星 · 06-03
欧康医药(920230)披露回购股份注销完成暨股份变动公告,6月3日股价下跌0.93%
6月3日山外山跌7.22%,圆信永丰医药健康A基金重仓该股
证券之星 · 06-03
6月3日山外山跌7.22%,圆信永丰医药健康A基金重仓该股
先声药业与普祺医药达成合作;和仁科技终止筹划控制权变更事项
21世纪经济报道 · 06-03
先声药业与普祺医药达成合作;和仁科技终止筹划控制权变更事项
基石医药股价两天累计跌超37%背后:其全球首创的这款抗癌药临床效果数据有所回落
红星资本局 · 06-02
基石医药股价两天累计跌超37%背后:其全球首创的这款抗癌药临床效果数据有所回落
泰格医药(300347.SZ):拟2亿元参投上海三生医药私募投资基金
智通财经 · 06-02
泰格医药(300347.SZ):拟2亿元参投上海三生医药私募投资基金
6月2日热景生物跌5.62%,富国医药创新股票A基金重仓该股
证券之星 · 06-02
6月2日热景生物跌5.62%,富国医药创新股票A基金重仓该股
医药LOF基金基金经理变动:增聘林嵩为基金经理
证券之星 · 06-02
医药LOF基金基金经理变动:增聘林嵩为基金经理
加载更多
公司概况
公司名称:
--
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"159938","market":"SZ","secType":"STK","nameCN":"医药","latestPrice":0.563,"timestamp":1780902189000,"preClose":0.574,"halted":0,"volume":93265066,"delay":0,"changeRate":-0.0192,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-0.011,"latestTime":"06-08 15:00:00","open":0.573,"high":0.574,"low":0.556,"amount":52613300,"amplitude":0.0314,"askPrice":0.564,"askSize":398,"bidPrice":0.563,"bidSize":1268,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780968600000},"marketStatusCode":5,"adr":0,"adjPreClose":0.574,"symbolType":"fund","openAndCloseTimeList":[[1780882200000,1780889400000],[1780894800000,1780902000000]],"highLimit":0.631,"lowLimit":0.517,"ibTradeSell":false,"ibTradeBuySell":true,"isCdr":false,"pbRate":0,"committee":0.29591,"marketValue":0,"turnoverRate":0,"status":1,"floatMarketCap":0},"requestUrl":"/m/hq/s/159938","defaultTab":"news","newsList":[{"id":"2641210764","title":"6月8日海创药业跌7.50%,鹏华医药科技股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641210764","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641210764?lang=zh_cn&edition=full","pubTime":"2026-06-08 16:43","pubTimestamp":1780908209,"startTime":"0","endTime":"0","summary":"证券之星消息,6月8日海创药业跌7.50%创60日新低,收盘报34.88元,换手率2.57%,成交量2.55万手,成交额9016.46万元。重仓海创药业的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共3家,其中持有数量最多的公募基金为鹏华基金的鹏华医药科技股票A。鹏华医药科技股票A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060800022208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","09939","BK1574","BK1161","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641105779","title":"医药外包概念股全线走低 金斯瑞生物科技(01548)跌7.43%、药明生物(02269)跌7.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2641105779","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641105779?lang=zh_cn&edition=full","pubTime":"2026-06-08 13:43","pubTimestamp":1780897412,"startTime":"0","endTime":"0","summary":"中邮证券表示,2026年第一季度,海外CXO行业整体呈现分化复苏格局,全球生物制药融资环境出现实质性改善,带动需求逐步回暖,但早期初创企业资金压力仍未完全缓解,不同细分赛道、不同规模企业的表现存在差异,行业结构性分化特征进一步凸显。展望2026年,海外头部CXO企业收入指引仍维持稳健小幅增长格局,叠加全球生物医药投融资逐步回暖、创新药研发需求稳步复苏,行业景气度延续上行态势,成长确定性进一步增强。","market":"other","thumbnail":"https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983281","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516738.SGD","LU2242644610.SGD","159938","LU0417516902.SGD","HK0000320264.USD","LU0456827905.SGD","02269","LU0516422440.USD","LU0348766576.USD","LU0516422952.EUR","LU0320764599.SGD","BK1515","HK0000320223.HKD","LU0039217434.USD","LU0307460666.USD","LU0140636845.USD","LU2045819591.USD","BK1191","LU0326950275.SGD","LU1046422090.SGD","BK1589","LU2039709279.SGD","09939","BK1521","LU0516423091.SGD","06127","SG9999002463.SGD","LU0516422366.SGD","03347","LU0359201612.USD","BK1141","LU1688375341.USD","01873","BK1574","LU1880383366.USD","LU3063872942.SGD","LU0051755006.USD","LU0856984785.SGD","LU1720050803.USD","LU0588546209.SGD","LU0348767384.USD","01548","LU0348735423.USD","02359","03759","LU0708995583.HKD","06821","HK0000306685.HKD","LU0572944931.SGD","01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641106434","title":"上药益药医药(上海)有限公司成立","url":"https://stock-news.laohu8.com/highlight/detail?id=2641106434","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641106434?lang=zh_cn&edition=full","pubTime":"2026-06-08 13:36","pubTimestamp":1780896960,"startTime":"0","endTime":"0","summary":"企查查APP显示,近日,上药益药医药(上海)有限公司成立,法定代表人为顾斌,注册资本为8亿元,经营范围包含:第一类医疗设备租赁;机械设备租赁;仓储设备租赁服务;数字创意产品展览展示服务等。企查查股权穿透显示,该公司由上海医药(601607)全资子公司上药控股有限公司、上海医药大健康云商股份有限公司共同持股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606083763482714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159938","BK1515","BK1574","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641411787","title":"大型医药股表现活跃,指数逆势收涨,医药ETF易方达(512010)本周“吸金”超8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2641411787","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641411787?lang=zh_cn&edition=full","pubTime":"2026-06-05 19:13","pubTimestamp":1780658013,"startTime":"0","endTime":"0","summary":"截至收盘,沪深300医药卫生指数上涨0.8%,中证生物科技主题指数上涨0.1%,中证创新药产业指数下跌0.02%,中证港股通医药卫生综合指数下跌0.8%,恒生港股通创新药指数下跌1.5%。Wind数据显示,医药ETF易方达(512010,联接基金A/C:001344/007883)本周前四个交易日连续获资金净流入,合计超8亿元。中信建投研报表示,医疗器械行业将迎来业绩修复和估值重塑。中国器械企业龙头持续创新、出海、并购,有望成长为全球医疗器械龙头,行业成长逻辑已从国产替代拓展到国际化和技术创新,估值迎来重塑机遇。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026060500035074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1515","159938","BK1574","512010","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641115053","title":"6月5日悦康药业跌15.77%,富国医药创新股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641115053","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641115053?lang=zh_cn&edition=full","pubTime":"2026-06-05 16:38","pubTimestamp":1780648713,"startTime":"0","endTime":"0","summary":"证券之星消息,6月5日悦康药业跌15.77%创60日新低,收盘报13.73元,换手率8.54%,成交量38.41万手,成交额5.46亿元。重仓悦康药业的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共7家,其中持有数量最多的公募基金为富国基金的富国医药创新股票A。富国医药创新股票A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500028298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK0239","159938","BK1515","BK1574","09939","688658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640815443","title":"创胜集团医药-B(06628)建议委任徐汉森为非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2640815443","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640815443?lang=zh_cn&edition=full","pubTime":"2026-06-04 19:21","pubTimestamp":1780572110,"startTime":"0","endTime":"0","summary":"智通财经APP讯,创胜集团医药-B 发布公告,徐汉森博士(徐博士)将获委任为非执行董事;及包骏博士(包博士)将获委任为独立非执行董事,惟均须待本公司股东于将于2026年6月30日召开的股东周年大会上批准后,方可作实。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450290.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","06628","BK1574","BK1161","159938","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640153649","title":"差异化创新破局,科望医药领航免疫治疗新蓝海","url":"https://stock-news.laohu8.com/highlight/detail?id=2640153649","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640153649?lang=zh_cn&edition=full","pubTime":"2026-06-04 16:41","pubTimestamp":1780562506,"startTime":"0","endTime":"0","summary":"当行业竞相追逐成熟靶点时,科望医药选择了更具挑战的源头创新之路,瞄准下一代免疫疗法,成为全球MCE赛道为数不多的定义者与领跑者。","market":"hk","thumbnail":"https://img2.gelonghui.com/d273d-c4393547-47e6-485a-a81d-c0fea64e5b84.jpg?guru_height=855&guru_width=1280&guru_size=118253","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/d273d-c4393547-47e6-485a-a81d-c0fea64e5b84.jpg?guru_height=855&guru_width=1280&guru_size=118253"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/5064974","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["09939","BK1515","BK1574","159938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640587161","title":"楚天科技:将楚天打造成世界医药领军企业之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2640587161","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640587161?lang=zh_cn&edition=full","pubTime":"2026-06-04 16:24","pubTimestamp":1780561450,"startTime":"0","endTime":"0","summary":"证券之星消息,楚天科技(300358)06月04日在投资者关系平台上答复投资者关心的问题。投资者提问:公司在多次访谈中提到'十五五'期间向百亿级企业迈进,请问公司十五五的总体目标是什么?有没有具体的量化目标?谢谢。楚天科技回复:您好!总体目标系将楚天打造成世界医药领军企业之一,谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400027690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0061","BK0077","159938","BK0251","BK0028","BK1574","BK1515","BK1161","09939","300358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640391611","title":"长春高新:公司管理团队涵盖医药、企管、财务、法务、金融等多元专业背景","url":"https://stock-news.laohu8.com/highlight/detail?id=2640391611","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640391611?lang=zh_cn&edition=full","pubTime":"2026-06-04 11:35","pubTimestamp":1780544129,"startTime":"0","endTime":"0","summary":"证券之星消息,长春高新(000661)06月04日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司管理层90%都是地产行业出身,缺少专业性,这是否也导致了公司研发销售管理效率全行业最低?长春高新回复:您好,相关表述与实际不符。公司管理团队涵盖医药、企管、财务、法务、金融等多元专业背景,各医药子公司经营、研发核心团队汇聚大批深耕生物医药领域的专业人才,适配整体经营管理需求,谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。相关 ETF","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400014462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","09939","000661","BK1574","159940","BK0188","159938","BK1515","BK0057","BK0046","BK1161","BK0075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640135180","title":"国产双靶点GLP-1迎新进展,翰森制药减重新药申报获受理|医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2640135180","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640135180?lang=zh_cn&edition=full","pubTime":"2026-06-04 09:57","pubTimestamp":1780538268,"startTime":"0","endTime":"0","summary":"截至6月3日收盘,市场冲高回落,沪深两市成交额3.13万亿元。医药ETF(512120)下跌1.46%,港股通生物科技ETF(159102)下跌3.11%。相关个股方面,金斯瑞生物科技上涨10.54%、信达生物下跌2.54%、百济神州下跌2.13%、药明生物下跌7.00%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606043760000889.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606043760000889.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","BK1583","BK1574","BK1589","BK4144","09939","159938","BK4590","GLP","BK1161","03692","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640818021","title":"和誉-B(02256):和誉医药于PAGE会议展示ABSK-011(依帕戈替尼)在HCC患者中的联合建模新框架","url":"https://stock-news.laohu8.com/highlight/detail?id=2640818021","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640818021?lang=zh_cn&edition=full","pubTime":"2026-06-04 08:04","pubTimestamp":1780531491,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和誉-B(02256)发布公告,公司的附属公司上海和誉生物医药科技有限公司(和誉医药)宣布,公司在2026年6月2日至5日于克罗地亚杜布罗夫尼克举行的欧洲群体药理学会议(PAGE会议)上,以壁报形式展示了两项基于模型的药物开发新进展。其中一项报告重点展示了一种创新的联合建模框架,用于预测高选择性FGFR4抑制剂ABSK-011(依帕戈替尼)在晚期FGF19+肝细胞癌(HCC)患者中的无进展生存期(PFS)。此外,和誉医药与外部合作方共同展示了一项基于国内自主研发的创新建模软件Maspectra完成的ABSK-011群体药代动力学建模研究,其中包括与NONMEM的比较分析。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449906.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","09939","IE00B543WZ88.USD","BK1574","BK4006","LU2476274720.SGD","02256","IE00B5MMRT66.SGD","LU2476274308.USD","BK1515","IE00BPRC5H50.USD","LU2488822045.USD","LU2778985437.USD","BK1161","HCC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640751906","title":"宏辉果蔬推进业务结构升级,7亿元控股施美药业拓展医药赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2640751906","media":"长三角资本局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640751906?lang=zh_cn&edition=full","pubTime":"2026-06-03 19:07","pubTimestamp":1780484820,"startTime":"0","endTime":"0","summary":"宏辉果蔬近期围绕治理结构、资产配置和产业布局持续推进调整。在生鲜果蔬行业竞争加剧、成本波动加大的背景下,公司通过控制权变更后的内部改革、低效资产处置及外延并购,推动业务结构由单一生鲜主业向多元化经营延伸。 整体来看,宏辉果蔬过去一年围绕控制权、资产结构、财务质量和产业布局完成多项调整。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/csjzbj/2026-06-03/doc-iniactak2317148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","BK1574","09939","603336","BK0238","159938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640084779","title":"星昊医药(920017)披露2025年年度权益分派实施公告,6月3日股价下跌0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640084779","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640084779?lang=zh_cn&edition=full","pubTime":"2026-06-03 17:45","pubTimestamp":1780479900,"startTime":"0","endTime":"0","summary":"截至2026年6月3日收盘,星昊医药报收于16.21元,较前一交易日下跌0.06%,最新总市值为20.24亿元。近日,星昊医药发布《2025年年度权益分派实施公告》。公告显示,公司2025年年度权益分派方案已获股东会审议通过,以股权登记日应分配股数123,892,517股为基数,每10股派6.000000元人民币现金,共计派发现金红利74,335,510.20元。本次权益分派不涉及送红股或转增股本。股权登记日为2026年6月10日,除权除息日为2026年6月11日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300036483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","09939","BK1161","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640490824","title":"欧康医药(920230)披露回购股份注销完成暨股份变动公告,6月3日股价下跌0.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640490824","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640490824?lang=zh_cn&edition=full","pubTime":"2026-06-03 17:44","pubTimestamp":1780479888,"startTime":"0","endTime":"0","summary":"截至2026年6月3日收盘,欧康医药报收于10.6元,较前一交易日下跌0.93%,最新总市值为10.65亿元。近日,欧康医药发布《回购股份注销完成暨股份变动公告》。公告显示,公司通过股份回购专用证券账户回购242,892股,占回购前总股本的0.24%。公司已于2026年6月1日完成上述股份的注销手续。注销完成后,公司股份总额由100,717,495股变更为100,474,603股,剩余库存股为0股。股权结构方面,有限售条件股份由53,469,747股减少至53,226,855股,无限售条件股份比例由46.91%上升至47.02%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300036467.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK1161","09939","159938","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640977331","title":"6月3日山外山跌7.22%,圆信永丰医药健康A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640977331","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640977331?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:36","pubTimestamp":1780475803,"startTime":"0","endTime":"0","summary":"证券之星消息,6月3日山外山跌7.22%,收盘报15.29元,换手率3.55%,成交量11.36万手,成交额1.78亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共8家,其中持有数量最多的公募基金为圆信永丰基金的圆信永丰医药健康A。圆信永丰医药健康A目前规模为2.66亿元,最新净值1.789,较上一交易日下跌1.79%,近一年上涨3.63%。圆信永丰医药健康A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300033451.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK0251","BK1574","688410","159938","09939","BK1161","150219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640922332","title":"先声药业与普祺医药达成合作;和仁科技终止筹划控制权变更事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2640922332","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640922332?lang=zh_cn&edition=full","pubTime":"2026-06-03 08:02","pubTimestamp":1780444935,"startTime":"0","endTime":"0","summary":"政策动向开展消化介入类医用耗材产品信息集中维护国家组织高值医用耗材联合采购办公室发布《关于开展消化介入类医用耗材产品信息集中维护工作的通知》显示,按照工作安排,将于2026年6月1日起开展消化介入类医用耗材产品信息集中维护工作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606033758181427.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606033758181427.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159938","300550","BK1583","BK1191","BK0231","BK0146","BK1515","BK1574","09939","BK1161","02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640172929","title":"基石医药股价两天累计跌超37%背后:其全球首创的这款抗癌药临床效果数据有所回落","url":"https://stock-news.laohu8.com/highlight/detail?id=2640172929","media":"红星资本局","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640172929?lang=zh_cn&edition=full","pubTime":"2026-06-02 19:16","pubTimestamp":1780399017,"startTime":"0","endTime":"0","summary":"红星资本局6月2日消息,继6月1日股价暴跌超32%后,6月2日,基石药业(2616.HK)大幅低开,截至收盘,股价跌7.54%,报5.03港元/股,总市值80.49亿港元,股价最近两日累计跌超37%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606023757689380.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","09939","BK1515","159938","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640917470","title":"泰格医药(300347.SZ):拟2亿元参投上海三生医药私募投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2640917470","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640917470?lang=zh_cn&edition=full","pubTime":"2026-06-02 19:05","pubTimestamp":1780398322,"startTime":"0","endTime":"0","summary":"智通财经APP讯,泰格医药(300347.SZ)发布公告,公司拟通过杭州泰格股权投资合伙企业(有限合伙)(简称“投资主体”)参与投资上海三生医药私募投资基金合伙企业(有限合伙)(简称“合伙企业”或“基金”)。合伙企业首期拟认缴出资总额为9.5亿元,投资主体将作为该合伙企业的有限合伙人(LP)以其自有资金认缴出资2亿元。合伙企业投资方向聚焦于创新药物及高端制剂、高端医疗器械、生物技术、高端制药装备等领域。公司此次发起设立产业基金,可以结合公司在生物健康领域的专业优势,拓展公司投资渠道,获取投资收益。同时该合作模式也将帮助公司提升综合服务能力,发展优质项目储备。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449201.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1576","03347","BK0077","BK0174","LU1820825898.SGD","BK1574","LU1146622755.USD","BK1161","BK1515","159938","300347","BK0216","BK0028","09939","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640915494","title":"6月2日热景生物跌5.62%,富国医药创新股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640915494","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640915494?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:31","pubTimestamp":1780389116,"startTime":"0","endTime":"0","summary":"证券之星消息,6月2日热景生物跌5.62%,收盘报81.0元,换手率2.0%,成交量1.86万手,成交额1.5亿元。重仓热景生物的前十大公募基金请见下表:该股最近90天内共有2家机构给出评级,买入评级2家。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共24家,其中持有数量最多的公募基金为富国基金的富国医药创新股票A。富国医药创新股票A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200030867.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","09939","BK0239","BK1574","688068","159938","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640995016","title":"医药LOF基金基金经理变动:增聘林嵩为基金经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2640995016","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640995016?lang=zh_cn&edition=full","pubTime":"2026-06-02 09:31","pubTimestamp":1780363871,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年6月2日,鹏华中证医药指数发布公告,增聘林嵩为基金经理,任职日期自2026年6月2日起,张羽翔不再担任该基金基金经理,离任日期为2026年6月2日,变更后鹏华中证医药指数的基金经理为林嵩。截止2026年6月1日,鹏华中证医药指数净值为0.7529,较上一日下跌0.79%,近一年下跌6.73%。2015年4月加盟鹏华基金管理有限公司,历任量化及衍生品投资部量化研究员、投资经理等,现担任指数与量化投资部副总监/基金经理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200010680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1161","159938","09939","BK1515"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780914969773,"stockEarnings":[{"period":"1week","weight":-0.0449},{"period":"1month","weight":-0.1059},{"period":"3month","weight":-0.1031},{"period":"6month","weight":-0.1433},{"period":"1year","weight":-0.1115},{"period":"ytd","weight":-0.1156}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0318},{"period":"3month","weight":-0.0234},{"period":"6month","weight":0.032},{"period":"1year","weight":0.1902},{"period":"ytd","weight":0.0148}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医药(159938)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医药(159938)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医药,159938,医药股票,医药股票老虎,医药股票老虎国际,医药行情,医药股票行情,医药股价,医药股市,医药股票价格,医药股票交易,医药股票购买,医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医药(159938)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医药(159938)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}